Page 223 - Genentech News Today

SAE Media Group reports: Visit the website and view the full programme and speaker line-up for the AI in Drug Discovery Conference in 2023

Investegate announcements from Oxford BioDynamics, OBD in San Francisco for JPM Healthcare conf 2023

/PRNewswire/ -- The "Global Biosimilars Partnering Terms and Agreements 2010 to 2022" report has been added to ResearchAndMarkets.coms offering. The Global...

  OSLO, Norway, December 19, 2022 / B3C newswire / -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that it has entered into a strategic manufacturing partnership with Richter-Helm BioLogi...

Novavax is significantly boosting its spending on lobbying.

Investegate announcements from Oxford BioDynamics, Initial assessment of EpiSwitch assay in ALS trial

Investegate announcements from F. Hoffmann-La Roche Ltd, CHMP recommends expansion of EU label for Hemlibra to include people with moderate haemophilia A

As respiratory illnesses continue to spread, you may have noticed some gaps in the shelves when searching for medicine. If you haven’t gotten sick this year,...

/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce a collaboration with...

/PRNewswire/ -- Emtrain will serve as Ciscos exclusive DEI training partner for a global initiative that will provide anti-discrimination and inclusive...